Adherence biomarker measurements in older and younger HIV-infected adults receiving tenofovir-based therapy
Journal of Acquired Immune Deficiency Syndromes | Feb 16, 2018
Viral drug resistance through 48 weeks, in a phase 2b, randomized, controlled trial of the HIV-1 attachment inhibitor prodrug, fostemsavir
Journal of Acquired Immune Deficiency Syndromes | Feb 15, 2018
Rapid serological tests ineffectively screen for HIV exposure in HIV-positive infants
Journal of Acquired Immune Deficiency Syndromes | Feb 15, 2018
Dolutegravir in pregnancy-Effects on HIV-positive women and their infants
European Journal of Clinical Microbiology & Infectious Diseases | Feb 07, 2018